Skip to main content
. 2022 Feb;23(2):695–701. doi: 10.31557/APJCP.2022.23.2.695

Table 2.

Immune-Related Adverse Events among Cases of Gastric and Renal Cell Cancer

Grading, Number Requiring systemic
irAE subtype Grade1-2 Grade3-4 steroid
treatment, n (%)
Skin-related events 15 3 9 (50%)
Pneumonitis 3 5 6 (75%)
Endocrine-related events 1 0 1 (100%)
Increased transaminase 9 5 6 (43%)
Fever 2 0 0 (0%)
Diarrhea 3 2 3 (60%)
Thyroid dysfunction 12 1 0 (0%)
other 3 1 0 (0%)